IMR Press / CEOG / Volume 34 / Issue 4 / pii/2007065

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Combined inherited thrombophilia and adverse pregnancy outcome

Show Less
1 Department of Obstetrics and Gynaecology, University of Patras, Medical School, Rion (Greece)
2 Department of Internal Medicine, Division of Hematology, University of Patras, Medical School, Rion (Greece)
3 Medical Physics Department, University of Patras, Medical School, Rion (Greece)
Clin. Exp. Obstet. Gynecol. 2007, 34(4), 236–238;
Published: 10 December 2007
Abstract

Inherited thrombophilia has been suggested as a possible condition of increased susceptibility to adverse pregnancy outcomes. In our prospective study, we investigated the association between combined inherited thrombophilia and adverse pregnancy outcome in the South-Western Greek population. Three hundred and ninety-six healthy Greek women with spontaneous pregnancies were investigated for combinations of the three commonest thrombophilic mutations (Factor II G20210A, Factor V Leiden and MTHFR C677T) and followed for adverse preg­nancy outcomes. Statistical analysis was performed by Pearson’s chi-square test Four women (1%) had the FV Leiden/MTHFR T677T double genotype and two women (0.5%) had the FII G20210A/MTHFR T677T double genotype. Although the small number of cases of combined inherited thrombophilia, it seems that the presence of FY Leiden/MTHFR T677T double genotype increases the risk for placental abruption.

Keywords
Factor II G20210A
Factor V Leiden
MTHFR C677T
Combined inherited thrombophilia
Pregnancy outcome
Share
Back to top